Research News and Research

RSS

Exploring palliative care's positives and negatives

What if a new medication for severely ill patients had no role in curing them but made them feel much better despite being sick?

24 Oct 2011

US markets for neurosurgical and neurovascular devices to grow to $240 million by 2016

According to Millennium Research Group, the global authority on medical technology market intelligence, the market for the specialized devices used for neurosurgical and neurovascular treatments will grow to $240 million by 2016, driven largely by an aging population in the United States that will suffer an increasing incidence of conditions such as stroke, cerebral aneurysms and intracranial atherosclerosis disease.

From Medtronic 24 Oct 2011

Wal-Mart increases premium costs, cuts benefits

Costs for this employer's most popular health coverage plan will increase to about $15 per two-week pay period. It's current cost is $11 per pay period.

24 Oct 2011

Study finds measuring quality does improve care

The Wisconsin Collaborative for Healthcare Quality was founded on a simple premise: To improve the quality of health care, you must be able to measure it. ... Yet the premise that tracking the quality of care truly prods physicians to change the way they practice medicine has been more accepted than studied.

24 Oct 2011

Lundbeck's ONFI receives FDA approval for treating seizures associated with Lennox-Gastaut syndrome

Lundbeck Inc., a wholly owned subsidiary of H. Lundbeck A/S in Denmark, announced today that the U.S. Food and Drug Administration (FDA) has approved ONFI as adjunctive therapy for seizures associated with Lennox-Gastaut syndrome in patients two years and older.

24 Oct 2011

Retainers for primary care?

Given the financial and regulatory uncertainty engulfing most of the health care industry, retainer-based primary-care medical practices are doing just fine, industry executives say.

24 Oct 2011

Earlier Medicare enrollment period brings new round of ads

Open enrollment periods for health plans also focus the spotlight on how health coverage is likely to change in 2014 when key elements of the health law take effect.

24 Oct 2011

Comprehensive ADMESeq Research Screening Panel launched

RainDance Technologies, Inc., the Digital Biology Company, and Ambry Genetics, today announced the launch of a comprehensive targeted sequencing panel to screen genes involved with drug absorption, distribution, metabolism, and excretion (ADME) research. The ADMESeq Research Screening Panel enables researchers to simultaneously interrogate 242 known pharmacogenetic genes using next-generation sequencing (NGS) systems.

24 Oct 2011

Collagen crosslinking for keratoconus may receive FDA approval in 2012

Patients in the United States who have the cornea-damaging disease keratoconus may soon be able to benefit from a new treatment that is already proving effective in Europe and other parts of the world.

24 Oct 2011

First Edition: October 24, 2011

Today's headlines include a variety of health policy news developments, including speculation about how the Supreme Court might review the health law and what's happening with the super committee.

24 Oct 2011

HMS, EPFL to collaborate on 6 pioneering neuroengineering projects

Two of the world's leading universities are joining forces to combine neuroscience and engineering in order to alleviate human suffering caused by such neurological disabilities as paralysis and deafness. Scientists, engineers, and clinicians at Harvard Medical School (HMS) and Ecole Polytechnique F-d-rale de Lausanne (EPFL) will collaborate on six pioneering neuroengineering projects made possible thanks to a $3.6 million grant from the Bertarelli Foundation.

24 Oct 2011

SafeMinds praises UNEP's draft treaty ban on use of mercury in pharma products

SafeMinds applauds UNEP's draft treaty language which does not exempt the use of mercury in pharmaceutical products, including vaccines, from the global ban. Governmental regulators, public health officials and pharmaceutical companies have recognized that the toxicity of mercury in pharmaceutical and personal care products, to which people are directly exposed, justifies a preventive approach to minimize all exposures.

24 Oct 2011

Synergy commences plecanatide Phase II/III trial in chronic idiopathic constipation

Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.

24 Oct 2011

NeCEN centre for electron microscopy to open in Leiden

NeCEN, a new high quality centre for electron microscopy, opens its doors in Leiden on October 27th. NeCEN has two of the most advanced cryo-transmission electron microscopes worldwide.

24 Oct 2011

Arrowhead acquires RNA therapeutics assets from Roche

Arrowhead Research Corporation, today announced that it has acquired RNA therapeutics assets from Roche including the state-of-the-art research site in Madison, WI.

24 Oct 2011

U-M researchers to study new approach in halting downward spiral of diabetes

University of Michigan Health System researchers will use a $3.5 million federal grant to study a new approach in halting the downward spiral of diabetes.

24 Oct 2011

Six prominent surgeons receive ACS' Honorary Fellowship

Honorary Fellowship in the American College of Surgeons (ACS) was awarded to six prominent surgeons from South Africa, England, Ireland, Italy, The Netherlands, and the People's Republic of China last night during Convocation ceremonies that preceded the official opening of the College's 97th Annual Clinical Congress.

24 Oct 2011

UCSF academic surgeon wins ACS' 2011 Distinguished Service Award

The Board of Regents of the American College of Surgeons (ACS) presented Mary H. McGrath, MD, MPH, FACS, of San Francisco, CA, with the College's 2011 Distinguished Service Award on October 23, during its Annual Clinical Congress in San Francisco.

24 Oct 2011

SCI patients with autonomic dysfunction more likely to develop heart disease

New research from the Heart and Stroke Foundation and the Christopher and Dana Reeve Foundation may help explain why people with spinal cord injury (SCI) have a higher risk of developing heart disease.

24 Oct 2011

Physical abnormality in airway linked with autism

Autism and autistic spectrum disorders (ASD) are currently diagnosed primarily through subjective observation of autistic behaviors. However, new research, presented at CHEST 2011, the 77th annual meeting of the American College of Chest Physicians (ACCP), suggests that a physical abnormality in the airway may be a prominent indicator for autism and autistic spectrum disorders, making it a possible diagnostic marker for this disease.

24 Oct 2011